Sham Mailankody MBBS | Authors


CAR T-Cell Therapy Could Replace Auto Transplant in Multiple Myeloma

September 30, 2022

The depth and durability of responses seen with these CAR T-cell therapies in refractory myeloma is unprecedented and raises again the question of the role of up-front autologous stem cell transplant in the era of immune therapies, including CAR T-cell therapies.